6-week sprint got Canada's nod for AstraZeneca Covid-19 vaccine

Problems at AstraZeneca Plc’s European production site in January kicked off a six-week push to get a version of its Covid-19 vaccine made at an Indian facility approved by Canada’s drug regulator, acco­rding to the Canadian pharmaceutical company that filed the application. Last week, when Health Canada approved Astra­Zen­eca’s Covid-19 vaccine, it also cleared a version of the shot made by the Serum Institute of India (SII).

SII filed the application with a Can­adian partner, Verity Pharmaceuticals. Some.

This article is no longer available in our repository.

There could be multiple reasons for this.